Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Operating Officer sold 3,490 shares at $4.06 ($14,184)
  3. 4 Open-market sale Chief Patient Supply Officer sold 1,070 shares at $4.06 ($4,349)
  4. 4 Open-market sale Chief Medical Officer sold 849 shares at $4.06 ($3,451)
  5. 4 Open-market sale Chief Executive Officer sold 5,532 shares at $4.06 ($22,483)
  6. 4 Open-market sale Chief Executive Officer sold 2,782 shares at $5.20 ($14,452)
  7. 4 Open-market sale Chief Patient Supply Officer sold 2,939 shares at $3.58 ($10,536)
  8. 4 Open-market sale Chief Operating Officer sold 4,375 shares at $4.26 ($18,659)
  9. 4 Open-market sale Chief Patient Supply Officer sold 1,907 shares at $4.26 ($8,133)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Chief Executive Officer sold 2,794 shares at $4.37 ($12,210)
  19. 4 Open-market buy Director bought 12,600 shares at $0.79 ($9,954)
  20. 4 Option exercise Chief Business Officer acquired 1,785,000 shares (option exercise)

Page 7 of 18 · 351 filings